Back to Trials
NCT06623318NARecruiting

IV Ensure in Patients Receiving OPAT

IV Ensure

Start Date

8/23/2023

Completion Date

11/1/2024

Summary

The purpose of remote therapeutic monitoring is to provide oversight and evaluation of patients receiving IV medications in the home setting post-acute. The goal is to improve patient outcomes and decrease re-admission rates for related diagnoses due to poor adherence. Remote therapeutic monitoring provides data used in the determination of dates, times, and duration of doses administered in the home setting to support real-time intervention by dedicated care managers to support improved adherence with prescribed dosing regiments. The objectives of the study are to: 1. Determine adherence rates for IV medications administered in the home. 2. Assess re-admission against adherence rates.

Eligibility Criteria

Age Range: 18 years to No maximum

Inclusion Criteria: * Adult patients enrolled in OPAT (IV antibiotic therapy) discharged to the home setting will be included in the study. Exclusion Criteria: * Patients enrolled in OPAT (IV antibiotic therapy) discharged to nursing homes, SNF (Skilled Nursing Facility), and pediatric patients will be excluded from the study.

Interventions

DEVICE

Remote therapeutic monitoring device

Interested in This Trial?

Contact the trial locations directly using the information below to learn more about enrollment.

Expressing interest lets you review the study and consent before we connect you with the research site.

Conditions

Determine If Adherence Rates with IV Antibiotics in OPAT Have a Correlation to Hospital Readmission Rates

Locations

The University of Oklahoma Health Sciences Center

Oklahoma City, Oklahoma 73104

United States